Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Faes Farma SA

+ Add to Watchlist

FFEA:GR

2.310 EUR 0.009 0.39%

As of 10:03:08 ET on 05/29/2015.

Snapshot for Faes Farma SA (FFEA)

Open: 2.380 Day's Range: 2.290 - 2.380 Volume: 0
Previous Close: 2.301 52wk Range: 1.540 - 2.439 1-Yr Rtn: +15.85%

Stock Chart for FFEA

No chart data available.
  • FFEA:GR 2.380
  • 1D
  • 1M
  • 1Y
2.301
Interactive FFEA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FFEA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 19.2500
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 0.1200
Est. PEG Ratio -
Market Cap (M EUR) 572.69
Shares Outstanding (M) 247.92
30 Day Average Volume 69
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.03%
Cash Dividend (EUR) 0.0503
Dividend Ex-Date 12/15/2014
5 Year Dividend Growth 3.88%
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FFEA

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for FFEA

Faes Farma, S.A. develops, manufactures and markets pharmaceutical products throughout Spain and, through its subsidiary, Laboratorios Vitoria S.A., in Portugal. The Company's principal prescription products combat cardiovascular, respiratory, central nervous system, musculoskeletal and osteoporosis related ailments.

Mariano Ucar AnguloChairmanFrancisco Quintanilla GuerraGeneral Director
Gonzalo Lopez CasanuevaGeneral DirectorValentin Ruiz UnamunzagaDeputy Gen Dir/CFO
More Company Profile & Key Executives for FFEA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil